Anthera Pharmaceuticals, Inc.
ANTH · OTC
3/31/2018 | 12/31/2017 | 9/30/2017 | 6/30/2017 | |
|---|---|---|---|---|
| Market Cap | $6,947 | $23,612 | $15,764 | $16,421 |
| - Cash | $8,086 | $2,196 | $6,076 | $11,151 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1,139 | $21,416 | $9,688 | $5,270 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$7 | -$8 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EBITDA | -$10,810 | -$9,220 | -$7,873 | -$8,499 |
| % Margin | – | – | – | – |
| Net Income | -$4,434 | -$10,056 | -$4,659 | $9,285 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.76 | -0.43 | 0.92 |
| % Growth | 73.7% | -76.7% | -146.7% | – |
| Operating Cash Flow | -$9,381 | -$6,260 | -$6,198 | -$10,113 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9,381 | -$6,260 | -$6,198 | -$10,113 |